Sale!

ETFDH Gene Glutaric acidemia type 2C Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ETFDH gene plays a critical role in the body’s energy production process, particularly in the metabolism of fats. Mutations in this gene can lead to a rare metabolic disorder known as Glutaric Acidemia Type 2C. This condition is characterized by the body’s inability to properly process certain fats and proteins, leading to a buildup of harmful substances and potentially severe health consequences if left untreated.

To diagnose this condition, genetic testing can be performed to identify mutations in the ETFDH gene. In the United Arab Emirates, DNA Labs UAE offers a comprehensive genetic test for Glutaric Acidemia Type 2C. This test is crucial for confirming the diagnosis, understanding the severity of the condition, and guiding treatment options.

The cost of the ETFDH Gene Glutaric Acidemia Type 2C Genetic Test at DNA Labs UAE is 4400 AED. This investment is vital for early detection and management of the condition, potentially preventing serious complications and improving the quality of life for affected individuals.

Description

ETFDH Gene Glutaric acidemia type 2C Genetic Test

Components: ETFDH Gene Glutaric acidemia type 2C Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ETFDH Gene Glutaric acidemia type 2C NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glutaric acidemia type 2C.

Test Details: ETFDH gene, also known as electron transfer flavoprotein dehydrogenase gene, is associated with a rare genetic disorder called glutaric acidemia type 2C (GA2C). GA2C is an autosomal recessive disorder characterized by the deficiency of electron transfer flavoprotein (ETF) and ETF dehydrogenase.

A NGS genetic test refers to Next-Generation Sequencing, a high-throughput sequencing technology that allows for the rapid and cost-effective analysis of a large number of genes simultaneously. In the context of GA2C, a NGS genetic test can be used to analyze the ETFDH gene to identify any pathogenic variants or mutations that may be present.

The NGS genetic test for ETFDH gene can help in the diagnosis of GA2C by identifying specific genetic changes that are associated with the disorder. This information can be useful for confirming the diagnosis, providing accurate genetic counseling, and guiding the management and treatment of affected individuals.

It is important to note that genetic testing should be performed by qualified healthcare professionals who specialize in genetics, as they can provide appropriate interpretation and guidance based on the results. Additionally, genetic testing may not be necessary or appropriate for all individuals, and its use should be determined on a case-by-case basis in consultation with a healthcare provider.

Test Name	ETFDH Gene Glutaric acidemia type 2C Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ETFDH Gene Glutaric acidemia type 2C NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glutaric acidemia type 2C
Test Details	ETFDH gene, also known as electron transfer flavoprotein dehydrogenase gene, is associated with a rare genetic disorder called glutaric acidemia type 2C (GA2C). GA2C is an autosomal recessive disorder characterized by the deficiency of electron transfer flavoprotein (ETF) and ETF dehydrogenase. A NGS genetic test refers to Next-Generation Sequencing, a high-throughput sequencing technology that allows for the rapid and cost-effective analysis of a large number of genes simultaneously. In the context of GA2C, a NGS genetic test can be used to analyze the ETFDH gene to identify any pathogenic variants or mutations that may be present. The NGS genetic test for ETFDH gene can help in the diagnosis of GA2C by identifying specific genetic changes that are associated with the disorder. This information can be useful for confirming the diagnosis, providing accurate genetic counseling, and guiding the management and treatment of affected individuals. It is important to note that genetic testing should be performed by qualified healthcare professionals who specialize in genetics, as they can provide appropriate interpretation and guidance based on the results. Additionally, genetic testing may not be necessary or appropriate for all individuals, and its use should be determined on a case-by-case basis in consultation with a healthcare provider.